Business Description
Gin Hwa Biotech Inc
ISIN : TW0007806002
Total Employee Number:
88Description
Gin Hwa Biotech Inc is engaged in developing completely original products to achieve every vision. Its Services and technology are Product Development, OEM Service, Core Technology, R & D Center, Professional Production, and Others.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.51 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | 1.7 | |||||
Interest Coverage | 40.53 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.27 | |||||
Beneish M-Score | -2.17 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 26.7 | |||||
3-Year EBITDA Growth Rate | 7.5 | |||||
3-Year EPS without NRI Growth Rate | 10.1 | |||||
3-Year Book Growth Rate | 68.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.77 | |||||
9-Day RSI | 38.4 | |||||
14-Day RSI | 37.66 | |||||
3-1 Month Momentum % | -17.53 | |||||
6-1 Month Momentum % | -19.66 | |||||
12-1 Month Momentum % | -10.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.56 | |||||
Quick Ratio | 2.05 | |||||
Cash Ratio | 0.68 | |||||
Days Inventory | 86.08 | |||||
Days Sales Outstanding | 95.74 | |||||
Days Payable | 32.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.73 | |||||
Dividend Payout Ratio | 0.32 | |||||
Forward Dividend Yield % | 1.73 | |||||
5-Year Yield-on-Cost % | 1.73 | |||||
3-Year Average Share Buyback Ratio | -4.9 | |||||
Shareholder Yield % | -14.61 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 30.4 | |||||
Operating Margin % | 17.07 | |||||
Net Margin % | 13.99 | |||||
EBITDA Margin % | 25.25 | |||||
FCF Margin % | -43.96 | |||||
OCF Margin % | 14.63 | |||||
ROE % | 12.97 | |||||
ROA % | 8.23 | |||||
ROIC % | 10.13 | |||||
3-Year ROIIC % | 5.79 | |||||
ROC (Joel Greenblatt) % | 14.07 | |||||
ROCE % | 12.94 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 20 | |||||
PE Ratio without NRI | 20 | |||||
PS Ratio | 2.79 | |||||
PB Ratio | 2.19 | |||||
Price-to-Tangible-Book | 2.21 | |||||
Price-to-Operating-Cash-Flow | 19.44 | |||||
EV-to-EBIT | 18.57 | |||||
EV-to-EBITDA | 13.31 | |||||
EV-to-Revenue | 3.37 | |||||
EV-to-FCF | -7.63 | |||||
Price-to-Graham-Number | 1.4 | |||||
| Price-to-Net-Current-Asset-Value | 15.12 | |||||
Earnings Yield (Greenblatt) % | 5.38 | |||||
FCF Yield % | -13.98 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gin Hwa Biotech Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 538.649 | ||
| EPS (TTM) (NT$) | 2.895 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 24.53 | ||
| 14-Day RSI | 37.66 | ||
| 14-Day ATR (NT$) | 1.444295 | ||
| 20-Day SMA (NT$) | 59.038571 | ||
| 12-1 Month Momentum % | -10.81 | ||
| 52-Week Range (NT$) | 55.6 - 79.9 | ||
| Shares Outstanding (Mil) | 29.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gin Hwa Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gin Hwa Biotech Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 1.000000 Cash Dividend | 2026-07-27 | 59.05 (-0.48%) | ||
| 1.05:1 Stock Split | 2026-07-27 | 59.05 (-0.48%) | ||
| TWD 0.940533 Cash Dividend | 2025-07-04 | 64.43 (+3.32%) |
Show
Entries
Gin Hwa Biotech Inc Frequently Asked Questions
What is Gin Hwa Biotech Inc(ROCO:7806)'s stock price today?
The current price of ROCO:7806 is NT$57.90. The 52 week high of ROCO:7806 is NT$79.90 and 52 week low is NT$55.60.
When is next earnings date of Gin Hwa Biotech Inc(ROCO:7806)?
The next earnings date of Gin Hwa Biotech Inc(ROCO:7806) is .
Does Gin Hwa Biotech Inc(ROCO:7806) pay dividends? If so, how much?
The Dividend Yield %  of Gin Hwa Biotech Inc(ROCO:7806) is 1.73% (As of Today), Highest Dividend Payout Ratio of Gin Hwa Biotech Inc(ROCO:7806) was 0.33. The lowest was 0.33. And the median was 0.33. The  Forward Dividend Yield % of Gin Hwa Biotech Inc(ROCO:7806) is 1.73%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Gin Hwa Biotech Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers